Key Takeaways — Chapter 20: SBIR/STTR

The big picture

The SBIR and STTR programs are federal set-asides that fund small for-profit businesses to commercialize innovation — non-dilutive seed funding (no equity taken), across eleven participating agencies. They demand a way of thinking pure researchers find foreign: SBIR/STTR funds the commercialization of innovation, not research for its own sake. You must pass two tests — technical merit and commercial potential — because the agency acts like an early investor buying a future product, not a grantor buying a paper.

Key takeaways

  • What they are. Non-dilutive federal funding for small businesses to turn innovation into products — "America's Seed Fund." A deliberate financing strategy for a technology company, not just "grants for science."
  • Threshold concept. SBIR/STTR funds commercialization, not research for its own sake. Pass both the technical-merit and commercial-potential tests; a brilliant technology with no commercialization case loses to a feasible one that has it.
  • Three-phase ladder. Phase I (feasibility — small/short), Phase II (development — larger/longer, usually requires Phase I), Phase III (commercialization — not SBIR-funded; private/revenue/non-SBIR contracts). Plan the whole climb from the start.
  • SBIR vs. STTR. SBIR — company-led, PI primarily employed by the business, most work in-house. STTR — requires a research-institution partner (minimum share, commonly ~30%), PI need not be employed by the business (enabling a faculty founder). University spinouts often start STTR, then move to SBIR.
  • The agencies differ. Topic/mission-driven (DOD, NASA — answer a named topic, often contracts) vs. investigator-initiated (NIH, NSF — bring your idea within broad areas, grants). Match technology to agency and style; talk to the program manager early; don't spray.
  • The commercialization plan is decisive: market (bottom-up, real customers), value proposition, competition, IP, path to market, team (business and technical), and Phase III financing. Build the whole proposal as one integrated investment case.

Action items

  1. Confirm small-business eligibility (size and ownership rules) and choose SBIR vs. STTR.
  2. Match your technology to the right agency and topic/style; contact the SBIR program manager to confirm fit.
  3. Draft Phase I technical objectives — the specific feasibility you'll prove — designed to feed Phase II.
  4. Build a real commercialization plan — talk to actual customers; analyze real competitors; plan Phase III financing.
  5. Start registrations (SAM.gov/UEI, SBIR.gov registry, agency system) now; map the full phase ladder.

Common mistakes

  • Treating an SBIR like a small research grant — all science, no business case (the afterthought commercialization section).
  • Asserting a "huge market" with a copied top-down number, no named customers, no honest competition analysis.
  • Applying to the wrong agency or off-topic (fatal at topic-driven agencies like DOD/NASA).
  • Forgetting SBIR doesn't fund Phase III and failing to plan non-SBIR commercialization financing.
  • Choosing SBIR when STTR fits (or trying to subcontract the majority of work to a university under SBIR).

Decision framework — "Is SBIR/STTR right, and how do I approach it?"

  1. Am I (or will I form) an eligible small business with a commercially promising technology? → If not, this isn't the route.
  2. SBIR or STTR? → Need a research-institution partner / faculty PI? → STTR. Can do R&D in-house? → SBIR.
  3. Which agency and style? → Match technology to mission; topic-driven (answer the topic) vs. investigator-initiated (bring your idea); talk to the program manager.
  4. Can I pass both tests? → Rigorous feasibility and an evidenced commercialization plan. Strengthen the business case before applying if it's thin.
  5. Have I planned the whole ladder and cleared the gates? → Phase I→II→III financing mapped; registrations done early.

🔁 Carry this forward: SBIR/STTR completes Part III's formal-funder tour with its merit-and-market hybrid. One funder world remains: international and multilateral funding (Chapter 21), where everything you've learned meets cross-border, multi-jurisdictional, and currency complexity. Then Part IV shifts from who funds to the craft questions that cut across all funders — resubmission, collaboration, AI, equity, and managing the award you've won.